It’s Easy to Prescribe Tandem

Prescribe the automated insulin delivery system that’s rated #1 in clinical outcomes and overall satisfaction by healthcare professionals.¹

Get started through the Tandem Pump Rx Portal for the most streamlined prescribing experience, or download our SMN to fax directly to our hub.

Launch Rx Portal

t:slim X2 insulin pump and Tandem Mobi system

Smarter Pump, Better Access

Now available Via pharmacy benefits

Tandem Diabetes Care insulin pumps are broadly covered through the pharmacy and durable medical equipment (DME) channels, so there are more ways for your patients to get the technology they need.

Broad Coverage

We’ve expanded coverage to help more patients access Tandem products, with preferred placement on the Express Scripts National Preferred Formulary.

Cost and Coverage

Our Pump Specialists can help patients navigate their benefits and identify available financial assistance, including copay cards, for those who qualify.

Get in Touch

Patients can rely on our Customer Care team for individualized guidance and support. Available 24 hours a day and 7 days a week at (877) 801-6901.

Now patients have an easy pathway to best-in-class outcomes

Most Customers Pay as Little as $0 Down

Most pay less than $50 a month, and more than 30% pay $0 out-of-pocket (including pump supplies).² Tandem will verify your patients’ benefits and guide them through next the steps. The sooner they start, the sooner they get Day 1 improvements.³

Launch Rx Portal

Ben, diagnosed 2024, and Izzy, diagnosed 2016

HAVE QUESTIONS? For additional support, download our guide for prescribing Tandem pumps.

References

1. Seagrove Partners HCP Perspectives (Devices), September 2025 Insulin Delivery Section N=120.

2. $50 monthly claim: Cost per month calculation reflects the average monthly out-of-pocket cost for pump and disposables necessary to utilize Tandem pump therapy over the life of the 48-month pump warranty. Assumes consumption of 10 infusion sets and cartridges per month. $0 out of pocket claim based on direct orders from Tandem customers with commercial insurance from 1/1/2025-12/31/2025. Data on file. Actual cost may vary and is subject to individual insurance coverage.

3. Beck RW, et al. Diabetes Technol Ther. 2023;25(5):329-342.

Important Safety Information

RX ONLY.

Indications for Use

Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.

t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.

Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.

Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.

Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin.  This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.